Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
about
Reporter-Expressing, Replicating-Competent Recombinant ArenavirusesLujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaksReverse Genetics Approaches for the Development of Influenza VaccinesDevelopment of live-attenuated arenavirus vaccines based on codon deoptimizationProteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.Lassa Virus Reverse Genetics.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Development of Recombinant Arenavirus-Based Vaccines.
P2860
Q26742028-712B8DD1-644F-4D4B-A2B6-FFCC5078037EQ27010420-C3EFE252-4439-4A18-B878-B319D2F01436Q28076140-15020A22-5317-4F28-8280-F036DC28999BQ35487706-70D5D4B2-87CE-494F-8F95-133B4E9D66FEQ37433998-34166666-EEF5-4752-B8F6-5AE20C241ED6Q37543755-592F1C70-EFCD-470A-B3F2-8B919F0F7C6BQ37546745-AE7D5156-C0FB-4AD7-BE3F-3D450357B79EQ38818648-4325FD8C-3ABD-4F76-885B-6B2442C527CBQ40056797-08BA9373-7BEC-4923-989A-C88C0A393A1BQ40156113-4E25DB76-E4FC-414A-9A8E-C34D2131404BQ40259618-34C5F21A-BB4D-4642-80AA-E40D4F7569AD
P2860
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@en
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@nl
type
label
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@en
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@nl
prefLabel
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@en
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
@nl
P2093
P2860
P356
P1476
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells
@en
P2093
Benson Y H Cheng
Emilio Ortiz-Riaño
Juan Carlos de la Torre
P2860
P356
10.3791/50662
P577
2013-08-01T00:00:00Z